Login to Your Account

Chinese investors buy stake in Italian biopharma NMS

By Pearl Liu
Staff Writer

Wednesday, January 10, 2018

HONG KONG – A consortium of Chinese investors will acquire a 90 percent stake in innovative oncology treatment developer Group NMS Co. Ltd., of Milan, Italy. The total value of the deal, including equity injection and debt restructuring, is around €300 million (US$361.25 million).

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription